SEC Info - Harvard Bioscience Inc.

SEC Info℠

Home

My Interests

Help

Please Sign In

Harvard Bioscience Inc.
MA
SEC # 1123494

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

*As Of*	*Filing*	*Page*	*Title*	*Docs.*

3/7/24	10-K	1	Business	1
		1	Certain Relationships and Related Transactions, and Director Independence	1
		1	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	1
4/3/24	DEF 14A	1	Code of Business Conduct and Ethics	2
		1	Compensation Discussion and Analysis	2
11/7/23	10-Q	1	Condensed Consolidated Financial Statements (unaudited)	3
3/7/24	10-K	1	Consolidated Balance Sheets	4
		1	Consolidated Statements of Cash Flows	4
4/26/23	10-Q	1	Consolidated Statements of Comprehensive Income (Loss)	1
3/7/24	10-K	1	Consolidated Statements of Comprehensive Loss	3
		1	Consolidated Statements of Operations	4
		1	Consolidated Statements of Stockholders' Equity	4
		1	Controls and Procedures	4
		1	Cybersecurity	1
11/7/23	10-Q	1	Defaults Upon Senior Securities	3
4/3/24	DEF 14A	1	Delinquent Section 16(A) Reports	2
		1	Director Compensation	2
3/7/24	10-K	1	Directors, Executive Officers and Corporate Governance	1
		1	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	1
4/3/24	DEF 14A	1	Environmental, Social, and Governance	2
		1	Equity Compensation Plan Information	2
3/7/24	10-K	1	Executive Compensation	1
		1	Exhibit Index	1
11/7/23	10-Q	1	Exhibits	3
3/7/24	10-K	1	Exhibits, Financial Statement Schedules	1
		1	F-2	1
		1	F-3	1
		1	F-4	1
		1	F-5	1
		1	F-6	1
		1	F-7	1
		1	F-8	1
11/7/23	10-Q	1	Financial Information	3
3/7/24	10-K	1	Financial Statements and Supplementary Data	1
		1	Form 10-K Summary	1
4/3/24	DEF 14A	1	Independent Registered Public Accounting Firm	2
		1	Information About Our Executive Officers	2
		1	Information Regarding Directors	2
		1	Information Regarding the Board of Directors and Its Committees	2
3/7/24	10-K	1	Item 1	1
		1	Item 10	1
		1	Item 11	1
		1	Item 12	1
		1	Item 13	1
		1	Item 14	1
		1	Item 15	1
		1	Item 16	1
		1	Item 1A	1
		1	Item 1B	1
		1	Item 1C	1
		1	Item 2	1
		1	Item 3	1
		1	Item 4	1
		1	Item 5	1
		1	Item 6	1
		1	Item 7	1
		1	Item 7A	1
		1	Item 8	1
		1	Item 9	1
		1	Item 9A	1
		1	Item 9B	1
		1	Item 9C	1
		1	Legal Proceedings	4
8/8/23	10-Q	1	Management ' s Discussion and Analysis of Financial Condition and Results of Operations	1
3/7/24	10-K	1	Management's Discussion and Analysis of Financial Condition and Results of Operations	3
		1	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	1
		1	Mine Safety Disclosures	4
4/3/24	DEF 14A	1	Multiple Stockholders Sharing the Same Address	2
3/7/24	10-K	1	Notes to Consolidated Financial Statements	2
8/8/23	10-Q	1	Notes to Unaudited Consolidated Financial Statements	2
3/7/24	10-K	1	Other Information	4
4/3/24	DEF 14A	1	Other Matters	2
		1	Outstanding Equity Awards at Fiscal Year-End	1
4/5/23	DEF 14A	1	Outstanding Equity Awards At Fiscal Year-End-2022	1
3/7/24	10-K	1	Part I	1
11/7/23	10-Q	1	Part I -- Financial Information	3
3/7/24	10-K	1	Part Ii	1
11/7/23	10-Q	1	Part Ii -- Other Information	3
3/7/24	10-K	1	Part Iii	1
		1	Part Iv	1
4/3/24	DEF 14A	1	Pay Versus Performance	2
3/7/24	10-K	1	Principal Accounting Fees and Services	1
		1	Properties	1
4/3/24	DEF 14A	1	Proposal 1 Election of Directors	2
		1	Proposal 2 Ratification of Appointment of Independent Registered Public Accounting Firm	2
		1	Proposal 3 Advisory Vote on the Compensation of Our Named Executive Officers	2
4/5/23	DEF 14A	1	Proposal 4 Advisory Vote On Frequency Of Future Advisory Votes On The Compensation Of Our Named Executive Officers	1
4/3/24	DEF 14A	1	Proxy Statement	2
3/7/24	10-K	1	Quantitative and Qualitative Disclosures about Market Risk	4
		1	Report of Independent Registered Public Accounting Firm	1
4/3/24	DEF 14A	1	Report of the Audit Committee	2
3/7/24	10-K	1	Reserved	1
		1	Risk Factors	4
4/3/24	DEF 14A	1	Security Ownership of Certain Beneficial Owners and Management	2
3/7/24	10-K	1	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	1
		1	Signatures	4
4/3/24	DEF 14A	1	Stockholder Communications With the Board of Directors	2
4/5/23	DEF 14A	1	Submission Of Stockholder Proposals For The 2024 Annual Meeting	1
4/3/24	DEF 14A	1	Submission of Stockholder Proposals for the 2025 Annual Meeting	1
		1	Summary Compensation Table	1
3/7/24	10-K	1	Table of Contents	4
4/3/24	DEF 14A	1	Transactions With Related Persons	2
11/7/23	10-Q	1	Unregistered Sales of Equity Securities and Use of Proceeds	3
3/7/24	10-K	1	Unresolved Staff Comments	1
4/5/23	DEF 14A	1	2022 Summary Compensation Table	1

↑Top

Harvard Bioscience Inc. MA SEC # 1123494

182 Topics within the Past Year Past Two Years Past Three Years Past Four Years Past Five Years Entire Database

Harvard Bioscience Inc.
MA
SEC # 1123494

182 Topics
within the